Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers

Journal of Analytical Toxicology

Volumn 39, Issue 4, 2015, Pages 251-261

  Desrosiers, Nathalie A ^a,b   Ramaekers, Johannes G ^c   Chauchard, Emeline ^a,d   Gorelick, David A ^a,e   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITÉ DE NANTES   (France)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRONABINOL;

ACCURACY; ADULT; AGE; ANXIETY; ARTICLE; ATTENTION; BALLOON ANALOG RISK TASK; BEHAVIOR ASSESSMENT; BLOOD LEVEL; CANNABIS SMOKING; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DRONABINOL BLOOD LEVEL; FEMALE; GROUP DYNAMICS; HIGH RISK BEHAVIOR; HUMAN; HYPOTENSION; HYSTERESIS; IMPULSIVENESS; LIMIT OF QUANTITATION; MALE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCORING SYSTEM; TACHYCARDIA; WORKING MEMORY; YOUNG ADULT; ADOLESCENT; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; DRUG EFFECTS; EPIDEMIOLOGY; HEART RATE; MIDDLE AGED; PSYCHOLOGY; SHORT TERM MEMORY; SPATIAL MEMORY;

CANNABIS;

ADOLESCENT; ADULT; BLOOD PRESSURE; COGNITION; FEMALE; HEART RATE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MARIJUANA SMOKING; MEMORY, SHORT-TERM; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; RISK-TAKING; SPATIAL MEMORY; YOUNG ADULT;

EID: 84929667558     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkv012     Document Type: Article

References (59)

1. 2014) United Nations Office on Drugs and Crime,World Drug Report 2014, https://www.unodc.org/documents/wdr2014/World_Drug_ Report_2014_web.pdf (accessed December 2014).
2. Drummer, O.H., Kourtis, I., Beyer, J., Tayler, P., Boorman, M., Gerostamoulos, D. (2012) The prevalence of drugs in injured drivers. Forensic Science International, 215, 14-17.
3. 2009) 2007 National Roadside Survey of Alcohol and Drug Use by Drivers: Drug Results. National Highway Traffic Safety Administration Office of Behavioral Safety Research. http://www. nhtsa.gov/Driving+Safety/Research+&+Evaluation/ci.2007+ National+Roadside+Survey+of+Alcohol+and+Drug+Use+ by+Drivers.print (Accessed September 2014).
4. Bostwick, J.M. (2012) Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clinic Proceedings, 87, 172-186.
5. O'Connell, T.J., Bou-Matar, C.B. (2007) Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal, 4, 16.
6. Chait, L.D., Zacny, J.P. (1992) Reinforcing and subjective effects of oral delta-9-THC and smoked marijuana in humans. Psychopharmacology, 107, 255-262.
7. Curran, H.V., Brignell, C., Fletcher, S., Middleton, P., Henry, J. (2002) Cognitive and subjective dose-response effects of acute oral delta-9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology, 164, 61-70.
8. Hall, W., Solowij, N. (1998) Adverse effects of cannabis. The Lancet, 352, 1611-1616.
9. Hart, C.L., van Gorp, W., Haney, M., Foltin, R.W., Fischman, M.W. (2001) Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology, 25, 757-765.
10. Heishman, S.J., Stitzer, M.L., Bigelow, G.E. (1988) Alcohol and marijuana:comparative dose effect profiles in humans. Pharmacology Biochemistry & Behavior, 31, 1-8.
11. Lamers, C.T.J., Ramaekers, J.G. (2001) Visual search and urban city driving under the influence of marijuana and alcohol. Human Psychopharmacology, 16, 393-401.
12. Ramaekers, J.G., Berghaus, G., van Laar, M., Drummer, O.H. (2004) Dose related risk of motor vehicle crashes after cannabis use. Drug and Alcohol Dependence, 73, 109-119.
13. Ramaekers, J.G., Moeller, M.R., van Ruitenbeek, P., Theunissen, E.L., Schneider, E., Kauert, G. (2006) Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug and Alcohol Dependence, 85, 114-122.
14. Leweke, M., Kampmann, C., Radwan, M., Dietrich, D.E., Johannes, S., Emrich, H.M. et al. (1998) The effects of tetrahydrocannabinol on the recognition of emotionally charged words: an analysis using event-related brain potentials. Neuropsychobiology, 37, 104-111.
15. Fergusson, D.M., Horwood, L.J. (1997) Early onset cannabis use and psychosocial adjustment in young adults. Addiction, 92, 279-296.
16. Watts, W.D., Wright, L.S. (1990) The relationship of alcohol, tobacco, marijuana, and other illegal drug use to delinquency among Mexican-American, black, and white adolescent males. Adolescence, 15, 173-181.
17. White, H.R. Marijuana use and delinquency - a test of the independent cause hypothesis. In: Dembo, R. (ed.). Drugs and Crime. University Press of America, Landham, MD, 1993; 27-52.
18. Moskowitz, H. (1985) Marijuana and driving. Accident Analysis and Prevention, 17, 323-345.
19. Walsh, G.W., Mann, R.E. (1999) On the high road: driving under the influence of cannabis in Ontario. Canadian Journal of Public Health, 90, 260-263.
20. Ramaekers, J., Kauert, G., Theunissen, E., Toennes, S.,Moeller,M. (2009) Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology, 23, 266-277.
21. Bosker, W.M., Kuypers, K.P.C., Theunissen, E.L., Surinx, A., Blankespoor, R.J., Skopp, G. et al. (2012) Medicinal THC (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standardized Field Sobriety Tests. Addiction, 107, 1837-1844.
22. Theunissen, E.L., Kauert, G.F., Toennes, S.W., Moeller, M.R., Sambeth, A., Blanchard, M.M. et al. (2012) Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. Psychopharmacology (Berl), 220, 341-350.
23. Schwope, D., Scheidweiler, K., Huestis, M. (2011) Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry, 401, 1273-1283.
24. Jex, H.R., McDonnell, J.D., Phatak, A.V. (1966) A "critical" tracking task for manual control research. IEEE Transactions on Human Factors in Electronics, HFE-7, 138-145.
25. Moskowitz, H. (1973) Laboratory studies of the effects of alcohol on some variables related to driving. Journal of Safety Research, 5, 185-199.
26. Lejuez, C.W., Read, J.P., Kahler, C.W., Richards, J.B., Ramsey, S.E., Stuart, G.L. et al. (2002) Evaluation of a Behavioral Measure of Risk Taking: The Balloon Analogue Risk Task (BART). Journal of Experimental Psychology: Applied, 8, 75-84.
27. White, T.L., Lejuez, C.W., de Wit, H. (2008) Test-retest characteristics of the Balloon Analogue Risk Task (BART). Experimental and Clinical Psychopharmacology, 16, 565-570.
28. Hopko, D., Lejuez, C., Daughters, S., Aklin, W., Osborne, A., Simmons, B. et al. (2006) Construct Validity of the Balloon Analogue Risk Task (BART): Relationship with MDMA Use by Inner-City Drug Users in Residential Treatment. Journal of Psychopathology and Behavioral Assessment, 28, 95-101.
29. Tull, M.T., Trotman, A., Duplinsky, M.S., Reynolds, E.K., Daughters, S.B., Potenza, M.N. et al. (2009) The effect of posttraumatic stress disorder on risk-taking propensity among crack/cocaine users in residential substance abuse treatment. Depression and Anxiety, 26, 1158-1164.
30. White, T.L., Lejuez, C.W., de Wit, H. (2007) Personality and Gender Differences in Effects of d-Amphetamine on Risk Taking. Experimental and Clinical Psychopharmacology, 15, 599-609.
31. Mann, L., Burnett, P., Radford, M., Ford, S. (1997) The Melbourne decision making questionnaire: an instrument for measuring patterns for coping with decisional conflict. Journal of Behavioral Decision Making, 10, 1-19.
32. Cherpitel, C.J. (1993) Alcohol, Injury, and Risk-Taking Behavior: Data from a National Sample. Alcoholism: Clinical and Experimental Research, 17, 762-766.
33. Patton, J.H., Stanford, M.S., Barratt, E.S. (1995) Factor structure of the barratt impulsiveness scale. Journal of Clinical Psychology, 51, 768-774.
34. Zuckerman, M. Zuckerman-Kuhlman personality questionnaire (ZKPQ): an alternative five-factorial model. In: de Raad, B, ed. Big five assessment. Ashland, OH, US: Hogrefe & Huber Publishers 2002; 377-396.
35. Prentice, K.J., Gold, J.M., Carpenter,W.T., Jr. (2005) Optimistic bias in the perception of personal risk: patterns in schizophrenia. American Journal of Psychiatry, 162, 507-512.
36. Schwope, D.M., Karschner, E.L., Gorelick, D.A., Huestis, M.A. (2011) Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clinical Chemistry, 57, 1406-1414.
37. Lee, D., Milman, G., Barnes, A.J., Goodwin, R.S., Hirvonen, J., Huestis, M.A. (2011) Oral Fluid Cannabinoids in Chronic, Daily Cannabis Smokers During Sustained, Monitored Abstinence. Clinical Chemistry, 57, 1127-1136.
38. Skopp, G., Pötsch, L., Ganßmann, B., Mauden, M., Richter, B., Aderjan, R. et al. (1999) Freie und glucuronidierte Cannabinoide im Urin -Untersuchungen zur Einschätzung des Konsumverhaltens. Rechtsmedizin, 10, 21-28.
39. Desrosiers, N.A., Himes, S.K., Scheidweiler, K.B., Concheiro-Guisan, M., Gorelick, D.A., Huestis, M.A. (2014) Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry, 60, 631-643.
40. Schwope, D.M., Bosker, W.M., Ramaekers, J.G., Gorelick, D.A., Huestis, M.A. (2012) Psychomotor Performance, Subjective and Physiological Effects and Whole Blood D9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis. Journal of Analytical Toxicology, 36, 405-412.
41. Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H. et al. (2008) A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9-tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana. Journal of Psychopharmacology, 22, 441-451.
42. van Wel, J.H., Kuypers, K.P., Theunissen, E.L., Toennes, S.W., Spronk, D.B., Verkes, R.J. et al. (2013) Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users. British Journal of Pharmacology, 170, 1410-1420.
43. Kuypers, K.P., Samyn, N., Ramaekers, J.G. (2006) MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function. Psychoparmacology, 187, 467-475.
44. Ramaekers, J.G., Theunissen, E.L., de Brouwer, M., Toennes, S.W., Moeller, M.R., Kauert, G. (2011) Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Paychoparmacology, 214, 391-401.
45. Ilan, A.B., Gevins, A., Coleman, M., ElSohly, M.A., de Wit, H. (2005) Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behavioral Pharmacology, 16, 487-496.
46. Ilan, A.B., Smith, M.E., Gevins, A. (2004) Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology (Berlin), 176, 214-222.
47. Harvey, M.A., Sellman, J.D., Porter, R.J., Frampton, C.M. (2007) The relationship between non-acute adolescent cannabis use and cognition. Drug and Alcohol Review., 26, 309-319.
48. Hart, C.L., Ilan, A.B., Gevins, A., Gunderson, E.W., Role, K., Colley, J. et al. (2010) Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacology Biochemistry and Behavior, 96, 333-341.
49. Dumont, G., van Hasselt, J., de Kam, M., van Gerven, J., Touw, D., Buitelaar, J. et al. (2011) Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers. Journal of Psychopharmacology, 25, 478-489.
50. Bossong, M.G., Jager, G., van Hell, H.H., Zuurman, L., Jansma, J.M., Mehta, M.A. et al. (2012) Effects of Delta9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study. Journal of Cognitive Neuroscience, 24, 588-599.
51. Kanayama, G., Rogowska, J., Pope, H.G., Gruber, S.A., Yurgelun-Todd, D.A. (2004) Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berlin), 176, 239-247.
52. Smith, A.M., Longo, C.A., Fried, P.A., Hogan, M.J., Cameron, I. (2010) Effects of marijuana on visuospatial working memory: an fMRI study in young adults. Psychopharmacology (Berlin), 210, 429-438.
53. Miller, K.M., Price, C.C., Okun, M.S., Montijo, H., Bowers, D. (2009) Is the n-back task a valid neuropsychologicalmeasure for assessing working memory? Archives of Clinical Neuropsychology, 24, 711-717.
54. Jaeggi, S.M., Buschkuehl, M., Perrig,W.J., Meier, B. (2010) The concurrent validity of the N-back task as a working memory measure. Memory, 18, 394-412.
55. Kane, M.J., Conway, A.R., Miura, T.K., Colflesh, G.J. (2007) Working memory, attention control, and the N-back task: a question of construct validity. Journal of Experimental Psychology: Learning, Memory, and Cognition, 33, 615-622.
56. Lane, S.D., Cherek, D.R., Tcheremissine, O.V., Lieving, L.M., Pietras, C.J. (2005) Acute Marijuana Effects on Human Risk Taking. Neuropsychopharmacology, 30, 800-809.
57. Vadhan, N.P., Hart, C.L., van Gorp, W.G., Gunderson, E.W., Haney, M., Foltin, R.W. (2007) Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. Journal of Clinical and Experimental Neuropsychology, 29, 357-364.
58. McDonald, J., Schleifer, L., Richards, J.B., de Wit, H. (2003) Effects of THC on Behavioral Measures of Impulsivity in Humans. Neuropsychopharmacology, 28, 1356-1365.
59. Ponto, L.L., O'Leary, D.S., Koeppel, J., Block, R.I., Watkins, G.L., Richmond, J.C. et al. (2004) Effect of acute marijuana on cardiovascular function and central nervous system pharmacokinetics of [(15)O]water: effect in occasional and chronic users. Journal of Clinical Pharmacology, 44, 751-766.